RO88915B - Process for the preparation of 1-ethyl-1,4-dihydro-4-oxo--quinoline-3-carboxylic and 1-ethyl-1, 4-dihydro-4-oxo-1, 8-naphtiridin-3-carboxylic acid derivatives - Google Patents

Process for the preparation of 1-ethyl-1,4-dihydro-4-oxo--quinoline-3-carboxylic and 1-ethyl-1, 4-dihydro-4-oxo-1, 8-naphtiridin-3-carboxylic acid derivatives

Info

Publication number
RO88915B
RO88915B RO115120A RO11512084A RO88915B RO 88915 B RO88915 B RO 88915B RO 115120 A RO115120 A RO 115120A RO 11512084 A RO11512084 A RO 11512084A RO 88915 B RO88915 B RO 88915B
Authority
RO
Romania
Prior art keywords
ethyl
dihydro
oxo
carboxylic acid
quinoline
Prior art date
Application number
RO115120A
Other languages
Romanian (ro)
Other versions
RO88915A (en
Inventor
Jose Esteve Soler
Original Assignee
Provesan Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Provesan Sa filed Critical Provesan Sa
Publication of RO88915A publication Critical patent/RO88915A/en
Publication of RO88915B publication Critical patent/RO88915B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Inventia se refera la un procedeu pentru prepararea unor derivati ai acizilor 1-etil-1,4-dihidro-4-oxo-chinolin-3-carboxilic si 1-etil-1,4-dihidro-4-oxo-1,8-naftiridin-3-carboxilic cu formula generala I: (vezi formula) în care X reprezinta un atom de carbon sau de azot si R reprezinta un atom de hidrogen sau de fluor, constând din aceea ca un compus cu formula generala II: (vezi formula) în careX si R au semnificaâiile de mai sus, se trateaza cu 2,5-dimetil oxitetrahidrofuran, în mediu de acid acetic, eventual în amestec cu dimetilformaldehida în proportie de 1:1, dupa care compusi transformati, daca se doreste, în saruri de metale alcaline sau alcalino-pamântoase, acceptabile fiziologic, prin procedee în sine cunoscute.The invention relates to a process for the preparation of 1-ethyl-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and 1-ethyl-1,4- naphthyridine-3-carboxylic acid of the general formula I wherein X represents a carbon or nitrogen atom and R represents a hydrogen or fluorine atom consisting of a compound of the general formula II: ) in which X and R have the above meanings are treated with 2,5-dimethyl oxytetrahydrofuran in acetic acid medium, optionally in admixture with dimethylformaldehyde in a ratio of 1: 1, after which the compounds are converted, if desired, into salts of alkaline or alkaline earth metals, physiologically acceptable, by processes known per se.

RO115120A 1983-07-06 1984-07-03 Process for the preparation of 1-ethyl-1,4-dihydro-4-oxo--quinoline-3-carboxylic and 1-ethyl-1, 4-dihydro-4-oxo-1, 8-naphtiridin-3-carboxylic acid derivatives RO88915B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8311250A FR2548664B1 (en) 1983-07-06 1983-07-06 7- (PYRROL-L-YL) DERIVATIVES OF L-ETHYL-1,4-DIHYDRO-4-OXOQUINOLEIN-3-CARBOXYLIC ACIDS AND L-ETHYL-1,4-DIHYDRO-4-OXO- (1,8-NAPHTYRIDINE) ) -3-SUBSTITUTED CARBOXYLICS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS

Publications (2)

Publication Number Publication Date
RO88915A RO88915A (en) 1987-06-30
RO88915B true RO88915B (en) 1987-07-01

Family

ID=9290571

Family Applications (1)

Application Number Title Priority Date Filing Date
RO115120A RO88915B (en) 1983-07-06 1984-07-03 Process for the preparation of 1-ethyl-1,4-dihydro-4-oxo--quinoline-3-carboxylic and 1-ethyl-1, 4-dihydro-4-oxo-1, 8-naphtiridin-3-carboxylic acid derivatives

Country Status (6)

Country Link
JP (1) JPS6036482A (en)
FR (1) FR2548664B1 (en)
IN (1) IN161611B (en)
RO (1) RO88915B (en)
SU (1) SU1322980A3 (en)
ZA (1) ZA844693B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1221492B (en) * 1984-03-13 1990-07-06 Biochem Design Srl ACIDS 7- (1-PIRRIL) -E 7- (1-PIRROLI-DINIL) -6-FLUORO-1-ETHYL-1,4-DIIDRO-4-KETOCHINOLIN-3-CARBOXYLS WITH ANTI-MICROBIAL ACTIVITIES, THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOUNDS THAT CONTAIN THEM
US6080756A (en) * 1995-08-29 2000-06-27 Pfizer Inc. Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin
DK0992501T3 (en) * 1995-09-22 2002-10-28 Wakunaga Pharma Co Ltd Pyridonecarboxylic acid derivatives as antibacterial agents
SK286420B6 (en) * 1997-09-15 2008-09-05 The Procter & Gamble Company Derivative of quinolone structure, pharmaceutical composition comprising the same and their use
AU3192700A (en) 1999-03-17 2000-10-04 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions
MXPA02000103A (en) * 1999-07-01 2003-07-21 Wakunaga Pharma Co Ltd Quinolinecarboxylic acid derivative or salts thereof.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1006521A (en) * 1972-12-18 1977-03-08 Minoru Sugita Piperazine derivatives and process for preparing them
JPS5233694A (en) * 1975-09-09 1977-03-14 Dai Ichi Seiyaku Co Ltd Process for preparation of 6_nitro-1,8-naphthyridine derivatives
AR223983A1 (en) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co A PROCEDURE FOR PREPARING 6-HALOGEN-4-OXO-7- (1-PIPERAZINYL) -1,8-NAFTIRIDIN-3-CARBOXYLIC ACID DERIVATIVES

Also Published As

Publication number Publication date
ZA844693B (en) 1985-02-27
JPS6036482A (en) 1985-02-25
RO88915A (en) 1987-06-30
IN161611B (en) 1988-01-02
FR2548664A1 (en) 1985-01-11
SU1322980A3 (en) 1987-07-07
FR2548664B1 (en) 1986-03-21
JPH026756B2 (en) 1990-02-13

Similar Documents

Publication Publication Date Title
ES2042385B1 (en) PROCEDURES FOR THE PREPARATION OF ARIL (OR HETEROARIL) -PIPERAZINYL-ALKYLAZOLES DERIVATIVES.
UA5954A1 (en) METHOD FOR PRODUCING(±)-4-DI-(N-PROPYL)-AMINO-6-CARBAMOYL-1,3,4,5-TETERAHYDROBENZO (с,d) INDOL OR ITS PHARMACEUTICALLY ACCEPTABLE SALT
ES8801312A1 (en) A PROCEDURE FOR PREPARING ALANYL-PROLIN DERIVATIVES.
ES2000185A6 (en) PROCEDURE FOR PREPARING DERIVATIVES OF PIRIDONCABOXILICOS ACIDS
RO85270A (en) PROCESS FOR THE PREPARATION OF ERGOLINIL DERIVATIVES
RO88915B (en) Process for the preparation of 1-ethyl-1,4-dihydro-4-oxo--quinoline-3-carboxylic and 1-ethyl-1, 4-dihydro-4-oxo-1, 8-naphtiridin-3-carboxylic acid derivatives
RO82962B (en) PROCESS FOR THE PREPARATION OF CERTAIN DERIVATIVES OF CEFALOSPORINE
RO86257B (en) PROCEDURE FOR PREPARATION OF D-LACTIC ACID
RO86258B (en) Process for obtaining some flavan mono-, di- and tri-substituted derivatives
YU119084A (en) Process for making derivatives of 7-(pyrol-1-il) 1-ethyl-1,4-dihydro-4-oxo-hinoline-3-carboxilic acid and 7-(pyrol-1-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridine)-3-carboxilic acid
ES8605497A1 (en) Process for the preparation of storage-stable benzothiazole-sulfenamides.
ES2001677A6 (en) Process for the preparation of N-sulfamyl-3-(2-guanidino-thiazol-4-methylthio)-propionamidine
HUT49329A (en) Process for producing substituted pyridyl-alkyl-ketone derivatives
RO91141B (en) Process for the preparation of 2-oxindol-1-carboxamide derivatives
IT1175916B (en) NEW PROCEDURE FOR PREPARING PHARMACOLOGICALLY ACTIVE COMPOUNDS CONTAINING A SULFOXIDE GROUP
ZA929175B (en) 5,6-dihydro-dibenz(b,e)azepine-6,11-dione-11-oximes.
BG41127A3 (en) Method for preparing 1, 4- dihydropyridine derivatives
RO92739B1 (en) Process for obtaining gluconic acid
PL276887A1 (en) Method of obtaining derivatives of 2-aminetatrahydroisoquinoline
RO85820B (en) Process for preparing methyl-quinoxaline-1,4-dioxide derivatives
RO82486B1 (en) Process for preparing 2-amino-benzophenones substituted
RO82558B1 (en) Process for obtaining 1, 5-bis(5-nitrofurfuryliden) acetone
RO82265B1 (en) Double magnesium salt with organic acids and process for preparing the same
RO95508B1 (en) Process for preparing thiicyano pyrimidine
IL140976A0 (en) Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines